Supply Chain

2 McKinsey partners dish future of supply chain resiliency

To find out what resilience means and what strategies supply chain hospital leaders should take, Becker’s spoke with William Weinstein, a McKinsey partner who’s one of the leaders who serves healthcare providers with external spend, and Drew Ungerman, a McKinsey senior partner who advises healthcare clients on strategy. 

10 things providers should know about monkeypox

Monkeypox was declared a public health emergency last week, but many healthcare professionals feel confused about how to best prepare for a potential outbreak in their area. While they wait for clearer guidance from the CDC and their local health departments, there are key actions they can take, such as decreasing stigma about the disease …

10 things providers should know about monkeypox Read More »

The power of digital ecosystems to improve pharma supply chain operations [Sponsored]

A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.

Tracking the nation’s baby formula supply: 4 facts

As domestic manufacturers chug away at replenishing the nation’s supply and the federal government imports baby formula from around the world, it’s unclear what the nation’s current inventory is. Here are four things to know about the shortage that’s expected to last until July: 

Are generic drug prices too low?

Perhaps the answer is yes, if we want to have a more resilient supply chain. At least that is the argument from a commentary by Mattingly and Conti (2022): Several medications that patients need have been in short supply before and during the COVID-19 pandemic, including low-priced, off-patent generic drugs. The White House recently released …

Are generic drug prices too low? Read More »

PhRMA encourages Biden administration to pursue ambitious Indo-Pacific Economic Framework

Last fall, President Biden announced that the United States would explore development of an Indo-Pacific Economic Framework (IPEF) to deepen economic relations in the region and collaborate to address global economic challenges. In February, the administration published additional information regarding its plans. As officials from the U.S. Trade Representative (USTR), the U.S. Department of Commerce …

PhRMA encourages Biden administration to pursue ambitious Indo-Pacific Economic Framework Read More »

3D printers have proved their value to hospitals for limb-saving surgery, Covid-19 supply chain issues, and more [Sponsored]

A recent webinar sponsored by Formlabs underscored the value of 3D printing from a clinical perspective and offered insight on how commercial and regulatory players are thinking about this space.

FDA reaches agreement on medical device user fees 

The FDA would be allowed to collect at least $1.78 billion in user fees over five years under a reauthorization of the medical device user fee program, according to a series of recommendations from the agency and representatives from the medical device industry released March 22. 

US-Mexico border policy may spur plasma shortage

Some patient advocacy groups are voicing concerns that a federal policy blocking Mexican nationals from entering the U.S. to donate plasma could cause shortages of critical drugs used to treat neurological and autoimmune diseases, The Wall Street Journal reported March 9.

US transplant system needs an overhaul, advisory panel says

While a record-breaking 41,354 organ transplants were performed in the U.S. last year, the nation’s current organ transplantation system is inequitable, and more can be done to boost that number, according to a report published Feb. 25 from the National Academies of Sciences, Engineering and Medicine. 

The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk [Sponsored]

The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.